ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--Jun 4, 2007 - ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) announced today the presentation of data from its Quinamed(R) (amonafide dihydrochloride) phase 1/2a dose-escalation study, designed to identify a genotypically optimised...ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
-- Genotypically Optimized Dosing Results in Improved Tolerance and Evidence of Anticancer Activity -- MELBOURNE, Australia, and MENLO PARK, California U.S.A. June 04, 2007-ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) announced today the presentation of data from its Quinamed (amonafide di...Quinamed®: ChemGenex Pharmaceuticals
... of Quinamed® used at ... Quinamed® (amonafide dihydrochloride) is a synthetic organic ... In NCI-sponsored clinical studies with amonafide ...Amonafide Dihydrochloride (Quinamed®): ChemGenex Pharmaceuticals
Clinical trial study of amonafide dihydrochloride (Quinamed®) in the treatment of patients with prostate cancer refractory to hormone therapy and docetaxel at ChemGenexQuinamed® + ARA-C Effective for Secondary Acute Myeloid Leukemia
... of Quinamed® (amonafide, benzisoquinolinedione, ... Comments: Quinamed may be a very important addition to therapies available for poor-risk AML. ...Quinamed® + ARA-C Effective for Secondary Acute Myeloid Leukemia
Comments: Quinamed may be a very important addition to therapies available for ... Quinamed® + ARA-C Effective for Secondary Acute Myeloid Leukemia (6/17/2008) ...Drug Development In Pursuit of Personalized Medicine: ChemGenex ...
... efficacy of the drug, known as Quinamed, by calibrating the dose to a prostate ... two drugs in clinical trials, Quinamed and Cleflatonin, a drug in phase ...Genotypically Optimized Dosing Results In Improved Tolerance And ...
ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) has announced the presentation of data from its Quinamed® (amonafide dihydrochloride) phase 1/2a dose-escalation ...